#BEGIN_DRUGCARD DB04732

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C23H32BN3O5

# Chemical_IUPAC_Name:
[(1R)-3-methyl-1-[(2R)-2-{[(morpholin-4-yl)carbonyl]amino}-3-(naphthalen-1-yl)propanamido]butyl]boronic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:33 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID

# HET_ID:
M1N

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C23H32BN3O5/c1-16(2)14-21(24(30)31)26-22(28)20(25-23(29)27-10-12-32-13-11-27)15-18-8-5-7-17-6-3-4-9-19(17)18/h3-9,16,20-21,30-31H,10-15H2,1-2H3,(H,25,29)(H,26,28)/t20-,21+/m1/s1

# InChI_Key:
InChIKey=MQMHIOPMTAJOHV-RTWAWAEBSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4732

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
441.328

# Molecular_Weight_Mono:
441.243501615

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.89

# Predicted_LogS:
-4.2

# Predicted_Water_Solubility:
3.13e-02 g/l

# Primary_Accession_No:
DB04732

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
387442

# PubChem_Substance_ID:
46505262

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](CC(C)C)(NC(=O)[C@@]([H])(CC1=C2C=CC=CC2=CC=C1)NC(=O)N1CCOCC1)B(O)O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:38 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BX842578

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
prcA

# Drug_Target_1_Gene_Sequence:
>747 bp
TCAGCCCGACGATTCGCCGTCAGACTGCGGGCTTTCCTGGTCTACCAGCAACGCTTGCAG
GGCGGAGCCGGTGATGCGCCGGAACGCGCGCCGTGGCCGGTTGGCATCGAGAACGGCCAC
CTCTAAGCTGGCCACGCCAAGGGTGGGTTGATCACCACCCGAGGTGTCGGCACTGCCGGC
CCGCAATGCAGCGACCGCGATACGCAGGGCGTCGGTCAGGCTGGCGTTCTCGGCATACGA
CTCTTTGAGCGCGTTGGCGATCGGCTCCGTGGTGCCGCCCATCACCACGAAATGCGGCTC
GTCGGCGATCGACCCGTCGTAGGTAATACGATACAACTCAGGGCGTTTCGTCTCGCCGTA
ATGCGCCACCTCGGCCACACACAACTCAACCTCGTAGGGCTTGGCCTGTTCGGTGAAGAT
GGTGCCTAGAGTCTGCGCGTAGACATTGGCCAACTGCCGACCCGTGACGTCACGACGGTC
ATAGGCGTAACCGCGGGTGTCGGCGAACTGGATCCCGCCGCGGCGCAAATTGTCGAACTC
GTTGAACTTGCCCGCAGCCGCAAAACCCACCCGATCGTAGAGCTCACTGATCTTCTGCAG
CGACCGCGACGGATTCTCCGCGACGAACAGCACACCACCGGCATAGGCCAGCGCCACCAC
GCTTTTGGCCCGCGCAATGCCCTTACGCGCCAACTCGCTGCGCTCGCGCATCGCCTGCTC
AGGCGAGATGAAATACGGAAAACTCAC

# Drug_Target_1_General_Function:
Involved in threonine endopeptidase activity

# Drug_Target_1_General_References:
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5751

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
26881

# Drug_Target_1_Name:
Proteasome

# Drug_Target_1_Number_of_Residues:
248

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00227	Proteasome

# Drug_Target_1_Protein_Sequence:
>Proteasome
MSFPYFISPEQAMRERSELARKGIARAKSVVALAYAGGVLFVAENPSRSLQKISELYDRV
GFAAAGKFNEFDNLRRGGIQFADTRGYAYDRRDVTGRQLANVYAQTLGTIFTEQAKPYEV
ELCVAEVAHYGETKRPELYRITYDGSIADEPHFVVMGGTTEPIANALKESYAENASLTDA
LRIAVAALRAGSADTSGGDQPTLGVASLEVAVLDANRPRRAFRRITGSALQALLVDQESP
QSDGESSG

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
O33244

# Drug_Target_1_SwissProt_Name:
PSA_MYCTU

# Drug_Target_1_Synonyms:
Alpha subunit) PrcA
EC 3.4.25.1

# Drug_Target_1_Theoretical_pI:
5.19

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BX842578

# Drug_Target_2_GenBank_ID_Protein:
1483538

# Drug_Target_2_GeneCard_ID:
prcB

# Drug_Target_2_Gene_Name:
prcB

# Drug_Target_2_Gene_Sequence:
>867 bp
GTGACATCACCGAGTGTCCGGGAGTGGCGTGACGGTGGCCGCTGGCTGCCGACGGCTGTC
GGAAAGGTGTTCGTCCGGTCGGGGCCGGGCGACACGCCAACAATGCTCCTGCTGCATGGC
TATCCGTCCAGTTCGTTCGACTTCCGGGCGGTGATTCCACACCTGACCGGCCAGGCTTGG
GTAACGATGGATTTTCTGGGCTTTGGCTTGTCCGACAAGCCGCGCCCGCACCGGTACAGC
CTGCTGGAGCAGGCCCACCTGGTGGAAACGGTGGTCGCCCACACCGTGACCGGCGCGGTC
GTCGTGCTGGCCCACGACATGGGCACGTCGGTGACCACCGAGCTGCTAGCCCGTGATTTG
GACGGCCGGTTGCCGTTCGATCTCCGACGTGCGGTGCTGAGCAACGGCAGTGTGATCTTG
GAGCGGGCCAGCCTGCGTCCGATCCAGAAAGTACTGCGCAGCCCGCTTGGTCCGGTCGCT
GCCCGGCTGGTCAGCCGCGGTGGCTTCACACGAGGGTTTGGCCGGATCTTCTCCCCAGCG
CACCCGCTGTCGGCGCAGGAGGCCCAAGCCCAGTGGGAGTTGCTGTGCTACAACGACGGC
AACCGGATCCCGCACCTGCTGATCAGCTACCTCGACGAGCGGATACGGCACGCGCAGCGC
TGGCATGGCGCGGTCCGCGATTGGCCCAAACCGCTTGGGTTCGTGTGGGGACTCGACGAT
CCGGTGGCAACAACCAACGTGCTCAATGGACTACGGGAATTGCGCCCCAGCGCCGCCGTC
GTGGAACTGCCAGGGTTGGGCCACTACCCGCAGGTCGAGGCTCCCAAAGCATATGCCGAG
GCCGCGCTATCGCTGCTCGTCGACTAG

# Drug_Target_2_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_2_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
16468985	Lin G, Hu G, Tsu C, Kunes YZ, Li H, Dick L, Parsons T, Li P, Chen Z, Zwickl P, Weich N, Nathan C: Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity. Mol Microbiol. 2006 Mar;59(5):1405-16.
16468986	Hu G, Lin G, Wang M, Dick L, Xu RM, Nathan C, Li H: Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Mol Microbiol. 2006 Mar;59(5):1417-28.
17082771	Pearce MJ, Arora P, Festa RA, Butler-Wu SM, Gokhale RS, Darwin KH: Identification of substrates of the Mycobacterium tuberculosis proteasome. EMBO J. 2006 Nov 15;25(22):5423-32. Epub 2006 Nov 2.
18059281	Gandotra S, Schnappinger D, Monteleone M, Hillen W, Ehrt S: In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med. 2007 Dec;13(12):1515-20. Epub 2007 Dec 2.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6694

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
30304.7

# Drug_Target_2_Name:
Proteasome subunit beta

# Drug_Target_2_Number_of_Residues:
291

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00227	Proteasome

# Drug_Target_2_Protein_Sequence:
>Proteasome subunit beta
MTWPLPDRLSINSLSGTPAVDLSSFTDFLRRQAPELLPASISGGAPLAGGDAQLPHGTTI
VALKYPGGVVMAGDRRSTQGNMISGRDVRKVYITDDYTATGIAGTAAVAVEFARLYAVEL
EHYEKLEGVPLTFAGKINRLAIMVRGNLAAAMQGLLALPLLAGYDIHASDPQSAGRIVSF
DAAGGWNIEEEGYQAVGSGSLFAKSSMKKLYSQVTDGDSGLRVAVEALYDAADDDSATGG
PDLVRGIFPTAVIIDADGAVDVPESRIAELARAIIESRSGADTFGSDGGEK

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Component of the proteasome core, a large protease complex with broad specificity involved in protein turnover. The M.tuberculosis proteasome is able to cleave oligopeptides not only after hydrophobic but also after basic, acidic and small neutral residues. Identified substrates of the M.tuberculosis proteasome are the pupylated fabD, panB and mpa proteins. One function of the proteasome is to contribute to M.tuberculosis ability to resist killing by host macrophages, since the core proteasome is essential for persistence of the pathogen during the chronic phase of infection in mice. The mechanism of protection against bactericidal chemistries of the host's immune reponse probably involves the degradation of proteins that are irreversibly oxidized, nitrated, or nitrosated

# Drug_Target_2_SwissProt_ID:
O33245

# Drug_Target_2_SwissProt_Name:
PSB_MYCTU

# Drug_Target_2_Synonyms:
20S proteasome beta subunit
Proteasome core protein prcB

# Drug_Target_2_Theoretical_pI:
4.42

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04732
